SCOTIA CAPITAL INC.

Position in EYPT — EyePoint, Inc.

CIK 1335644 TORONTO, A6

Position in EYPT

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$538,170

-$38,961 QoQ

Shares Held

41,751

+32.2% QoQ

Ownership

0.050%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SCOTIA CAPITAL INC. holds $18,289,216 across 14 Biotechnology names. EYPT ranks #5 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EPRX	Eupraxia Pharmaceuticals Inc.	1,342,178	$9,717,368
2	BNTX	BioNTech SE	45,000	$3,999,600
3	VRTX	Vertex Pharmaceuticals Inc / Ma	4,861	$2,170,630
4	DFTX	Definium Therapeutics, Inc.	40,548	$766,357
5	EYPT	EyePoint, Inc. This page	41,751	$538,170
6	LXRX	Lexicon Pharmaceuticals, Inc.	159,831	$249,336
7	LGND	Ligand Pharmaceuticals Inc	1,164	$232,392
8	VKTX	Viking Therapeutics, Inc.	7,048	$229,341

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$538,170	41,751	+32.2%	Shares	Defined	2026-05-13
2025-12-31	$577,131	31,589	0.0%	Shares	Defined	2026-02-12
2025-09-30	$449,827	31,589	0.0%	Shares	Defined	2025-11-14
2025-06-30	$297,252	31,589	0.0%	Shares	Defined	2025-08-13
2025-03-31	$171,212	31,589	+154.3%	Shares	Defined	2025-05-09
2024-12-31	$92,536	12,421	0.0%	Shares	Defined	2025-02-13
2024-09-30	$99,243	12,421	0.0%	Shares	Defined	2024-11-13
2024-06-30	$108,062	12,421	+38.6%	Shares	Defined	2024-08-14
2023-12-31	$207,134	8,963	-90.1%	Shares	Defined	2024-02-12
2023-09-30	$726,794	90,963	+144.9%	Shares	Defined	2023-11-14
2023-06-30	$323,144	37,143	—	Shares	Defined	2023-08-03
No filing history on record for this holder in this stock.